Are exon 19 deletions and L858R different in early stage lung adenocarcinoma?

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

    Yiliang Zhang, Fudan University Shanghai Cancer Center, Fudan University Shanghai Medical College, Yuan Ma, Fudan University Shanghai Cancer Center, Fudan University Shanghai Medical College, Yuan Li, Fudan University Shanghai Cancer Center, Fudan University Shanghai Medical College, Xuxia Shen, Fudan University Shanghai Cancer Center, Fudan University Shanghai Medical College,
  • Yongfu Yu
  • Yunjian Pan, Fudan University Shanghai Cancer Center, Fudan University Shanghai Medical College, Yang Zhang, Fudan University Shanghai Cancer Center, Fudan University Shanghai Medical College, Su Yu, Fudan University Shanghai Cancer Center, Fudan University Shanghai Medical College, Difan Zheng, Fudan University Shanghai Cancer Center, Fudan University Shanghai Medical College, Yue Zhao, Fudan University Shanghai Cancer Center, Fudan University Shanghai Medical College, Hong Hu, Fudan University Shanghai Cancer Center, Fudan University Shanghai Medical College, Yihua Sun, Fudan University Shanghai Cancer Center, Fudan University Shanghai Medical College, Yawei Zhang, Fudan University Shanghai Cancer Center, Fudan University Shanghai Medical College, Jiaqing Xiang, Fudan University Shanghai Cancer Center, Fudan University Shanghai Medical College, Haiquan Chen, Fudan University Shanghai Cancer Center, Fudan University Shanghai Medical College
Original languageEnglish
JournalJournal of Cancer Research and Clinical Oncology
Volume144
Issue number1
Pages (from-to)165-171
Number of pages7
ISSN0171-5216
DOIs
Publication statusPublished - 1 Jan 2018

    Research areas

  • Epidermal growth factor receptor (EGFR), Lung adenocarcinoma, Tyrosine kinase inhibitor (TKI)

See relations at Aarhus University Citationformats

ID: 129304087